Mitch is a leading life sciences corporate advisor with more than 35 years of experience guiding life sciences companies, investors, and financial institutions through pivotal capital markets and strategic transactions including business-critical corporate, financing, and strategic transactions that shape growth, access to capital, and long-term enterprise value. As global chair of Goodwin’s Life Sciences practice and a member of the firm’s Executive Committee, Mitch brings deep transactional experience and a broad perspective on the forces shaping the life sciences industry and its capital markets helping clients align legal strategy with commercial priorities, investor expectations, and market opportunities.
Experience
Mitch serves as a strategic advisor and primary outside counsel to founders, boards, management teams, investors, and financial institutions advising on critical decisions across the corporate lifecycle, from raising capital and accessing the public markets to executing strategic transactions and evaluating opportunities for growth. His practice is distinguished by the scale and breadth of his capital markets and M&A experience as well as his understanding of the commercial priorities and investor expectations that shape high-stakes decisions.
Representative Matters
Mitch has advised on more than $60 billion in capital markets and M&A transactions. Since 2017, he has been among the most active attorneys representing issuer-side life sciences IPOs in the United States.
Clients turn to Mitch for market-tested judgment on high-value capital markets and strategic transactions where timing, positioning, investor confidence, and execution certainty are critical.
Professional Experience
Prior to joining Goodwin, Mitch was a partner at Testa, Hurwitz & Thibeault in Boston, where he was a member of the Business Practice group and co-chair of its Life Sciences Practice.
Credentials
Education
JD1989
Boston College Law School
BS1986
Suffolk University
(cum laude)
Admissions
Bars
- Massachusetts
Recognition & Awards
Mitch is nationally recognized for his leadership in the life sciences industry. He is ranked Band 1 by Chambers for Nationwide Life Sciences; has been recognized numerous times by The Best Lawyers in America for Biotechnology and Life Sciences Practice, Corporate Law, and Venture Capital Law; has been included in The Legal 500 United States; and has been named a “Life Sciences Star” by LMG Life Sciences.